JR595

General

Type : Oxime, Pyridine-aldoxime, Morpholine

Chemical_Nomenclature : (E)-4-(4-(5-hydroxy-6-((hydroxyimino)methyl)pyridin-2-yl)butyl)morpholin-4-ium 2,2,2-trifluoroacetate

Canonical SMILES : C1(=C(N=C(C=C1)CCCCN2CCOCC2)C(=NO[H])[H])O[H].CC

InChI : InChI=1S\/C14H21N3O3\/c18-14-5-4-12(16-13(14)11-15-19)3-1-2-6-17-7-9-20-10-8-17\/h4-5,11,18-19H,1-3,6-10H2

InChIKey : PLDGQRNHDXKJKL-UHFFFAOYSA-N

Other name(s) :


MW : 279.33

Formula : C14H21N3O3

CAS_number :

PubChem :

UniChem : PLDGQRNHDXKJKL-UHFFFAOYSA-N

Target

Structure : No structure

Families : No family

References (1)

Title : Pharmacokinetic evaluation of brain penetrating morpholine-3-hydroxy-2-pyridine oxime as an antidote for nerve agent poisoning - Zorbaz_2020_ACS.Chem.Neurosci__
Author(s) : Zorbaz T , Misetic P , Probst N , Zunec S , Zandona A , Mendas G , Micek V , Macek Hrvat N , Katalinic M , Braiki A , Jean L , Renard PY , Gabelica Markovic V , Kovarik Z
Ref : ACS Chem Neurosci , : , 2020
Abstract :
PubMedSearch : Zorbaz_2020_ACS.Chem.Neurosci__
PubMedID: 32105443